HC Wainwright Forecasts Aemetis FY2030 Earnings

Aemetis, Inc (NASDAQ:AMTX) – Investment analysts at HC Wainwright issued their FY2030 earnings estimates for shares of Aemetis in a report released on Friday, March 13th. HC Wainwright analyst A. Dayal anticipates that the specialty chemicals company will earn $3.05 per share for the year. The consensus estimate for Aemetis’ current full-year earnings is ($2.07) per share.

Aemetis (NASDAQ:AMTX) last announced its quarterly earnings results on Thursday, March 12th. The specialty chemicals company reported ($0.24) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.28) by $0.04. The firm had revenue of $43.31 million during the quarter, compared to the consensus estimate of $72.07 million.

Other analysts have also recently issued reports about the company. Ascendiant Capital Markets cut their target price on Aemetis from $21.00 to $20.00 and set a “buy” rating on the stock in a research note on Wednesday, November 19th. Loop Capital set a $1.75 price objective on Aemetis in a report on Thursday, March 12th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Aemetis in a research note on Wednesday, January 21st. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Aemetis has a consensus rating of “Hold” and an average target price of $8.25.

Aemetis Trading Up 24.1%

Shares of NASDAQ:AMTX opened at $2.73 on Monday. The company has a 50-day moving average price of $1.59 and a 200-day moving average price of $1.89. The company has a market cap of $180.73 million, a price-to-earnings ratio of -2.05 and a beta of 2.61. Aemetis has a 12 month low of $1.22 and a 12 month high of $3.66.

Hedge Funds Weigh In On Aemetis

A number of large investors have recently made changes to their positions in AMTX. Catalyst Funds Management Pty Ltd purchased a new stake in shares of Aemetis during the 2nd quarter valued at $25,000. Creative Planning purchased a new position in Aemetis during the 2nd quarter worth $30,000. Virtu Financial LLC acquired a new position in Aemetis during the 4th quarter valued at about $31,000. HRT Financial LP acquired a new position in Aemetis during the 4th quarter valued at about $36,000. Finally, Centiva Capital LP purchased a new stake in Aemetis in the third quarter valued at about $39,000. 27.02% of the stock is owned by institutional investors and hedge funds.

About Aemetis

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.